Wyrick, Christopher D.
34  Ergebnisse:
Personensuche X
?
1

Tritiation of the cannabinoid receptor antagonist SR144528 ..:

Seltzman, Herbert H. ; Foster, Matthew C. ; Wyrick, Christopher D...
Journal of Labelled Compounds and Radiopharmaceuticals.  48 (2005)  8 - p. 589-596 , 2005
 
?
2

Tritiation of SR141716 by metallation–iodination–reduction:..:

Seltzman, Herbert H. ; Ivy Carroll, F. ; Burgess, Jason P...
Journal of Labelled Compounds and Radiopharmaceuticals.  45 (2001)  1 - p. 59-70 , 2001
 
?
3

Synthesis of 3β-(4-[125I]iodophenyl)tropane-2-β-pyrrolidine..:

Zhong, Desong ; Kotian, Pravin ; Wyrick, Christopher D....
Journal of Labelled Compounds and Radiopharmaceuticals.  42 (1999)  3 - p. 281-286 , 1999
 
?
4

Synthesis of [1-3H]morphine-6-β-D-glucuronide:

Berrang, Bertold D. ; Wyrick, Christopher D. ; Carroll, F. Ivy.
Journal of Labelled Compounds and Radiopharmaceuticals.  42 (1999)  9 - p. 851-857 , 1999
 
?
5

Protection of the allylic alcohol double bond from catalyti..:

Seltzman, Herbert H. ; Roche, Michael J. ; Laudeman, Christopher P...
Journal of Labelled Compounds and Radiopharmaceuticals.  41 (1998)  9 - p. 811-821 , 1998
 
?
 
?
7

Metallation/reduction as a new approach to tritium labeling..:

Seltzman, Herbert H. ; Odear, Denise F. ; Laudeman, Christopher P...
Journal of Labelled Compounds and Radiopharmaceuticals.  34 (1994)  4 - p. 367-375 , 1994
 
?
8

Synthesis of nona‐deutero olivetol and nona‐deutero cannabi..:

Seltzman, Herbert H. ; Begum, Mosammat K. ; Wyrick, Christopher D.
Journal of Labelled Compounds and Radiopharmaceuticals.  29 (1991)  9 - p. 1009-1018 , 1991
 
?
9

Discovery of the Bruton's Tyrosine Kinase Inhibitor Clinica..:

Sabat, Mark ; Dougan, Douglas R ; Knight, Beverly...
Journal of Medicinal Chemistry.  64 (2021)  17 - p. 12893-12902 , 2021
 
?
10

Correction to "Discovery of the Bruton's Tyrosine Kinase In..:

Sabat, Mark ; Dougan, Douglas R ; Ermolieff, Jacques...
Journal of Medicinal Chemistry.  64 (2021)  21 - p. 16318-16318 , 2021
 
?
 
?
 
1-15